Pulling SEC filings + quote and writing the call…

Hippo Holdings Inc.
Next earnings Aug 4, 2026 · consensus $-0.15 EPS, $143M rev
Last earnings -6.7% on 2026-04-30
First-ever profit at 13x earnings looks cheap, but $9M operating cash vs $58M net income says wait for proof.
P/E 13.0 · FY2025
Middling fundamentals offset by an attractive price (~192% below fair value) — worth a look on the value angle.
Hippo just did something it had never done in its history: turn a full-year GAAP profit. Revenue has compounded from $91M (FY2021) to $469M (FY2025, +25.9% YoY) while net income marched from a $371M loss to a $57.7M gain — a genuine inflection, not a rounding error. On the screen it looks cheap: 13.0x FY diluted EPS of $2.22, 1.6x sales, a 13.2% ROE and a 12.3% net margin. Diversification away from catastrophe-heavy HO3 homeowners toward Renters, Commercial Multi-Peril and Casualty (per the MD&A) is the right structural move for an insurer that the filing admits was whipsawed by 'severe weather in the second quarter of 2023' badly enough to pause writing new HO3 premium nationwide.
The reason to hold rather than buy is earnings quality. Net income was $57.7M but operating cash flow was just $9.2M — down 80.6% YoY. A 6x gap between reported profit and cash generation in an insurer is a flag: it suggests the profit leans on non-cash items, reserve movements, or investment marks rather than clean underwriting cash. One profitable year against a -$1.22B accumulated deficit is a data point, not a track record, and management explicitly warns 'we may not maintain profitability in the future' and that catastrophe volatility plus the expense-timing mismatch (marketing expensed now, premium earned over 12 months) can flip the P&L back to a loss. Liabilities/equity of 3.37x is normal for a carrier, but it leaves little cushion if reserves prove light.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 2, 2026, 11:29 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $91.2M | $120M | $210M | $372M | $469M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | -$371M | -$333M | -$273M | -$40.5M | $57.7M |
| Diluted EPS | -$34.11 | -$14.66 | -$11.58 | -$1.64 | $2.22 |
| Net margin | -407.2% | -278.5% | -130.2% | -10.9% | 12.3% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Item 5.02: executive/board change announced — officer or director appointed or departed
Item 5.07: annual meeting vote results (directors, say-on-pay, auditor ratification)
Q1 2026 10-Q: revenue growth and profitability held into the new year
Q1 2026 10-Q: revenue growth and profitability held into the new year
2026 proxy for annual meeting — board, executive pay, auditor votes
FY2025 10-K: first profitable year, revenue +26% to $469M, EPS $2.22
FY2025 results: first full-year GAAP profit, net income $57.7M, EPS $2.22
Q3 2025 10-Q: sustained profit; segments recast to one, premium diversifying
Q3 2025 10-Q: sustained profit; segments recast to one, premium diversifying
Sources: SEC EDGAR (CIK 0001828105, latest 10-Q filed 2026-04-30) · EODHD · Proprietary analysis · as of 7/3/2026, 3:29:02 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 1 sale
| 2026-06-10 | Boettcher Laura Chief Operating Officer | Award | 11.7K | |
| 2026-06-09 | McCathron Richard Chief Executive Officer | Sell | 5.00K @ $25.00 | $125K |
| 2026-06-03 | Ellis Stewart Director | Award | 4.82K | |
| 2026-06-02 | Fouche Lori Dickerson Director | Award | 4.74K @ $25.40 | $120K |
| 2026-06-02 | Fouche Lori Dickerson Director | Award | 4.81K | |
| 2026-06-02 | WIJNBERG SANDRA S Director | Award | 4.74K @ $25.40 | $120K |
| 2026-06-02 | WIJNBERG SANDRA S Director | Award | 4.81K | |
| 2026-06-02 | Hay Laura J Director | Award | 2.50K @ $25.40 | $63.6K |
| 2026-06-02 | Hay Laura J Director | Award | 4.81K | |
| 2026-06-02 | Holliday Susan Claire Director | Award | 2.50K @ $25.40 | $63.6K |
| 2026-06-02 | Holliday Susan Claire Director | Award | 4.81K | |
| 2026-06-02 | NICHOLS JOHN DRAKE Director | Award | 4.74K @ $25.40 | $120K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median